Emalex has secured a US patent for an orally disintegrating [...]

Allucent has appointed new therapeutic strategy leaders across key disease [...]

Cereno Scientific has reported initial long-term safety findings from a [...]

A new global initiative aims to address long-standing limitations in [...]

Efzimfotase alfa has shown positive Phase 3 results in children [...]

ImmuneOncia Therapeutics and Lonza have entered into a manufacturing collaboration [...]

UMass Chan Medical School, Caring Cross and Trenchant BioSystems have [...]

BridgeBio Pharma has submitted a New Drug Application (NDA) to [...]

Chiesi Global Rare Diseases has received a positive CHMP opinion [...]

  The FDA has granted breakthrough therapy designation to Hemab [...]